SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-13-015475
Filing Date
2013-11-27
Accepted
2013-11-27 16:12:09
Documents
2
Period of Report
2013-11-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bota20131127_8k.htm 8-K 28053
2 EXHIBIT 10.1 ex10-1.htm EX-10 102679
  Complete submission text file 0001437749-13-015475.txt   132265
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 131247987
SIC: 2836 Biological Products, (No Diagnostic Substances)